Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce A Sutcliffe

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of the New York Academy of Sciences|December 24, 2011
Antibiotics in development targeting protein synthesisJoyce A Sutcliffe
Current Opinion in Microbiology|August 23, 2005
Improving on nature: antibiotics that target the ribosomeJoyce A Sutcliffe
Journal of Microbiological Methods|June 9, 2012
Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription-translation assay system for evaluation of translation inhibitorsCorey Fyfe, Joyce A Sutcliffe, Trudy H Grossman
Clinical and Vaccine Immunology : CVI|May 6, 2011
Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvantTarek Hamouda, Joyce A Sutcliffe, Susan Ciotti, et al.
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Joyce A Sutcliffe, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coliTrudy H Grossman, William O'Brien, Kathryn O Kerstein, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parametersTrudy H Grossman, Chris M Pillar, Daniel F Sahm, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Evolution and global dissemination of macrolide-resistant group A streptococciD Ashley Robinson, Joyce A Sutcliffe, Wezenet Tewodros, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2015
Eravacycline (TP-434) is efficacious in animal models of infectionTrudy H Grossman, Timothy M Murphy, Andrew M Slee, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2018
Evaluation of the <i>In Vitro</i> Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic IsolatesDavid R Snydman, Laura A McDermott, Nilda V Jacobus, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|December 24, 2011
Antibiotics in development targeting protein synthesisJoyce A Sutcliffe
Current Opinion in Microbiology|August 23, 2005
Improving on nature: antibiotics that target the ribosomeJoyce A Sutcliffe
Journal of Microbiological Methods|June 9, 2012
Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription-translation assay system for evaluation of translation inhibitorsCorey Fyfe, Joyce A Sutcliffe, Trudy H Grossman
Clinical and Vaccine Immunology : CVI|May 6, 2011
Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvantTarek Hamouda, Joyce A Sutcliffe, Susan Ciotti, et al.
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Joyce A Sutcliffe, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coliTrudy H Grossman, William O'Brien, Kathryn O Kerstein, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parametersTrudy H Grossman, Chris M Pillar, Daniel F Sahm, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Evolution and global dissemination of macrolide-resistant group A streptococciD Ashley Robinson, Joyce A Sutcliffe, Wezenet Tewodros, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2015
Eravacycline (TP-434) is efficacious in animal models of infectionTrudy H Grossman, Timothy M Murphy, Andrew M Slee, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2018
Evaluation of the <i>In Vitro</i> Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic IsolatesDavid R Snydman, Laura A McDermott, Nilda V Jacobus, et al.
Pageof 3